Besides the direct involvement of BRAFV600E in thyroid tumor initiation and dedifferentiation, previous studies have reported an association of PTC with an immunosuppressive signature at mRNA level, as evidenced by the induction of the CTLA-4, PD-L1, and HLA-G genes [37]. This evidence concerns the gene CD274 and thyroid tumor.